Journal of Liver Cancer

Kyung Sik Kim

1 Article

Fever, Thrombocytopenia and the Deterioration of Liver Function after Open Surgical Radiofrequency Ablation Therapy: Jae Gil Lee, Suk Mo Kim, Kyung Sik Kim, Jong Yoon Won, Nae Chun Yoo, Dong Sup Yoon, Jin Sub Choi, Woo Jung Lee, Byong Ro Kim; Journal of the Korean Liver Cancer Study Group. 2005;5(1):71-74. Published online June 30, 2005

Abstract PDF: The surgical resection is the only curative modality for hepatocellular carcinoma (HCC); however the surgical approach is limited by residual function of liver and multiplicity of tumor. The radiofrequency ablation (RFA) is introduced recently as a therapeutic modality, an alternative to percutaneous ethanol injection therapy (PEIT) for HCC. The advantages of open surgical RFA include better cancer staging with open intraoperative ultrasound, the availability of an intraoperative ultrasound guide system, the accessibility to tumors in all areas of the liver, avoidance of adjacent organ injury, the ability to perform hepatic inflow occlusion which reduces the heat-sink effect, and the possibility of combining RFA with hepatic resection. The complications after open surgical radiofrequency ablation are rarely reported. A 59 year old man with fever, thrombocytopenia and the deterioration of liver function after open surgical RFA was experienced. The patient’s hepatic function was given a Child-Pugh score of A6 points and the value of ICG R15 test was 55.2%. The open surgical RFA was performed on the S2, S3, S4 and S8. Although the patient was fully recovered without sequelae by conservative managements, the inclusion criteria have to be established carefully through following reviews on clinical results after open surgical RFA.

Kyung Sik Kim

2 Articles

Surgical Treatment in Advanced Hepatocellular Carcinoma: Kyung Sik Kim; Journal of the Korean Liver Cancer Study Group. 2006;6(1):1-6. Published online June 30, 2006

Abstract PDF: Hepatic resection has been accepted as one of the most effective treatments for hepatocelluar carcinoma. The various advancements in both operative procedures and perioperative patient management have made the hepatic resection safer and the indications for resection have been also expanded. Recently the International Cooperative Study Group for hepatocellular carcinoma proposed a new staging based on data form multiple centers across the world. According to this new staging, the paradigm of managing advanced hepatocellular carcinoma is being changed. Therefore the experiences on the surgical approach to various situations such as larger HCC above 10 cm in diameter, vascular invasion and lymph node involvement were reviewed.

Sarcomatoid Hepatocellular Carcinoma: Jin Sub Choi, Kyung Sik Kim, Yong Nyun Park, Woo Jung Lee, Jae Yoon Chon, Jong Tae Lee, Byong Ro Kim; Journal of the Korean Liver Cancer Study Group. 2002;2(1):76-79. Published online July 31, 2002

Abstract PDF: A 64-year-old male was admitted due to liver mass. He had radical prostatectomy owing to prostate cancer 5 years ago. At that time, the liver mass was found on the right posterior superior segment and had enlarged to 7 cm in diameter at Nov. 2001. The transhepatic chemoembolization with adriamycin 50 mg and gelform was performed but the viable portions of tumor were remained. Total bilirubin was 0.7 mg/dL, Albumin 2.9 g/dL, AST/ALT 24/18 IU/L and AFP 60.31 ng/mL. The ICG R15 was 6.2%. The right lobectomy of liver was done and the pathologic results were sarcomatoid hepatocellular carcinoma. The level of AFP was decreased 2 month after operation but the patient was dead 4 month after operation because of the metastasis to the right psoas muscle and suspected peritoneal seeding.